{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:16:22Z","timestamp":1792199782396,"version":"4.4.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03760-8","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:35:44Z","timestamp":1731400544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of ocular surface inflammation and systemic conditions in patients with systemic lupus erythematosus: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-0035","authenticated-orcid":false,"given":"Yuerong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4815-619X","authenticated-orcid":false,"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-591X","authenticated-orcid":false,"given":"Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4772-9416","authenticated-orcid":false,"given":"Jianing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-7629","authenticated-orcid":false,"given":"Yingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-2184","authenticated-orcid":false,"given":"Huanmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-4082","authenticated-orcid":false,"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"3760_CR1","doi-asserted-by":"publisher","unstructured":"Narvaez J. Systemic lupus erythematosus 2020. Med Clin (Barc). 2020;155(11):494\u2013501. Lupus eritematoso sistemico 2020. https:\/\/doi.org\/10.1016\/j.medcli.2020.05.009.","DOI":"10.1016\/j.medcli.2020.05.009"},{"issue":"9","key":"3760_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515\u201332. https:\/\/doi.org\/10.1038\/s41584-021-00668-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"17","key":"3760_CR3","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1080\/14656566.2017.1403584","volume":"18","author":"C Rodriguez-Pomar","year":"2017","unstructured":"Rodriguez-Pomar C, Pintor J, Colligris B, Carracedo G. Therapeutic inhibitors for the treatment of dry eye syndrome. Expert Opin Pharmacother. 2017;18(17):1855\u201365. https:\/\/doi.org\/10.1080\/14656566.2017.1403584.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"3760_CR4","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81\u201396. https:\/\/doi.org\/10.7326\/AITC202006020.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3760_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3.","journal-title":"World J Pediatr"},{"issue":"Suppl5","key":"3760_CR6","doi-asserted-by":"publisher","first-page":"v12","DOI":"10.1093\/rheumatology\/keaa484","volume":"59","author":"R Capecchi","year":"2020","unstructured":"Capecchi R, Puxeddu I, Pratesi F, Migliorini P. New biomarkers in SLE: from bench to bedside. Rheumatology (Oxford). 2020;59(Suppl5):v12\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keaa484.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3760_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","volume":"80","author":"A Fanouriakis","year":"2021","unstructured":"Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update omicronn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14\u201325. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218272.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3760_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/ICU.0000000000000209","volume":"26","author":"JM Preble","year":"2015","unstructured":"Preble JM, Silpa-archa S, Foster CS. Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol. 2015;26(6):540\u20135. https:\/\/doi.org\/10.1097\/ICU.0000000000000209.","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"3760_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","volume":"100","author":"S Silpa-archa","year":"2016","unstructured":"Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135\u201341. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306629.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3760_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/ICU.0000000000000810","volume":"32","author":"I Lee","year":"2021","unstructured":"Lee I, Zickuhr L, Hassman L. Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine. Curr Opin Ophthalmol. 2021;32(6):583\u20139. https:\/\/doi.org\/10.1097\/ICU.0000000000000810.","journal-title":"Curr Opin Ophthalmol"},{"issue":"28","key":"3760_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004218","volume":"95","author":"A Chen","year":"2016","unstructured":"Chen A, Chen HT, Hwang YH, Chen YT, Hsiao CH, Chen HC. Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis. Medicine (Baltimore). 2016;95(28): e4218. https:\/\/doi.org\/10.1097\/MD.0000000000004218.","journal-title":"Medicine (Baltimore)"},{"key":"3760_CR12","doi-asserted-by":"publisher","first-page":"8509089","DOI":"10.1155\/2019\/8509089","volume":"2019","author":"A Wang","year":"2019","unstructured":"Wang A, Gu Z, Liao R, Shuai Z. Dry Eye Indexes Estimated by Keratograph 5M of Systemic Lupus Erythematosus Patients without Secondary Sjogren\u2019s Syndrome Correlate with Lupus Activity. J Ophthalmol. 2019;2019:8509089. https:\/\/doi.org\/10.1155\/2019\/8509089.","journal-title":"J Ophthalmol"},{"issue":"3","key":"3760_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. Jul2017;15(3):276\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008.","journal-title":"Ocul Surf"},{"key":"3760_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109121","volume":"221","author":"T Suarez-Cortes","year":"2022","unstructured":"Suarez-Cortes T, Merino-Inda N, Benitez-Del-Castillo JM. Tear and ocular surface disease biomarkers: A diagnostic and clinical perspective for ocular allergies and dry eye disease. Exp Eye Res. 2022;221: 109121. https:\/\/doi.org\/10.1016\/j.exer.2022.109121.","journal-title":"Exp Eye Res"},{"issue":"11S","key":"3760_CR15","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, de Paiva CS. The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology. 2017;124(11S):S4\u201313. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.010.","journal-title":"Ophthalmology"},{"key":"3760_CR16","doi-asserted-by":"publisher","unstructured":"Qiu Y, Hu B, Peng RM, Huang JF, Hong J. Tear Cytokines as Biomarkers for Acute Ocular Graft-Versus-Host Disease. Cornea. 2022.\u00a0https:\/\/doi.org\/10.1097\/ICO.0000000000002959.","DOI":"10.1097\/ICO.0000000000002959"},{"issue":"14","key":"3760_CR17","doi-asserted-by":"publisher","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","volume":"59","author":"T Yamaguchi","year":"2018","unstructured":"Yamaguchi T. Inflammatory Response in Dry Eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES192\u20139. https:\/\/doi.org\/10.1167\/iovs.17-23651.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3760_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108115","volume":"197","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020;197: 108115. https:\/\/doi.org\/10.1016\/j.exer.2020.108115.","journal-title":"Exp Eye Res"},{"issue":"6","key":"3760_CR19","doi-asserted-by":"publisher","first-page":"C1305","DOI":"10.1152\/ajpcell.00086.2020","volume":"318","author":"DG Puro","year":"2020","unstructured":"Puro DG. How goblet cells respond to dry eye: adaptive and pathological roles of voltage-gated calcium channels and P2X7 purinoceptors. Am J Physiol Cell Physiol. 2020;318(6):C1305\u201315. https:\/\/doi.org\/10.1152\/ajpcell.00086.2020.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"3760_CR20","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s00417-018-4065-y","volume":"256","author":"C Chao","year":"2018","unstructured":"Chao C, Golebiowski B, Stapleton F, Zhou X, Chen S, Madigan MC. Conjunctival MUC5AC+ goblet cell index: relationship with corneal nerves and dry eye. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2249\u201357. https:\/\/doi.org\/10.1007\/s00417-018-4065-y.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3760_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jtos.2019.11.005","volume":"18","author":"SK Swamynathan","year":"2020","unstructured":"Swamynathan SK, Wells A. Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration. Ocul Surf. 2020;18(1):19\u201326. https:\/\/doi.org\/10.1016\/j.jtos.2019.11.005.","journal-title":"Ocul Surf"},{"issue":"7","key":"3760_CR22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3346\/jkms.2011.26.7.938","volume":"26","author":"MH Kang","year":"2011","unstructured":"Kang MH, Kim MK, Lee HJ, Lee HI, Wee WR, Lee JH. Interleukin-17 in various ocular surface inflammatory diseases. J Korean Med Sci. 2011;26(7):938\u201344. https:\/\/doi.org\/10.3346\/jkms.2011.26.7.938.","journal-title":"J Korean Med Sci"},{"key":"3760_CR23","doi-asserted-by":"publisher","unstructured":"Peng X, Lu Y, Wei J, et al. A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjogren's syndrome patients with dry eye disease. Clin Exp Rheumatol. 2021;39 Suppl 133(6):159\u2013165. https:\/\/doi.org\/10.55563\/clinexprheumatol\/tlnr4z.","DOI":"10.55563\/clinexprheumatol\/tlnr4z"},{"issue":"9","key":"3760_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl5","key":"3760_CR25","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/keaa379","volume":"59","author":"M Aringer","year":"2020","unstructured":"Aringer M, Johnson SR. Classifying and diagnosing systemic lupus erythematosus in the 21st century. Rheumatology (Oxford). 2020;59(Suppl5):v4\u201311. https:\/\/doi.org\/10.1093\/rheumatology\/keaa379.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3760_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101441","volume":"45","author":"PK Akowuah","year":"2022","unstructured":"Akowuah PK, Adjei-Anang J, Nkansah EK, et al. Comparison of the performance of the dry eye questionnaire (DEQ-5) to the ocular surface disease index in a non-clinical population. Cont Lens Anterior Eye. 2022;45(3): 101441. https:\/\/doi.org\/10.1016\/j.clae.2021.101441.","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"3760_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jtos.2019.08.008","volume":"17","author":"H Pult","year":"2019","unstructured":"Pult H, Wolffsohn JS. The development and evaluation of the new Ocular Surface Disease Index-6. Ocul Surf. 2019;17(4):817\u201321. https:\/\/doi.org\/10.1016\/j.jtos.2019.08.008.","journal-title":"Ocul Surf"},{"issue":"5","key":"3760_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615\u201321. https:\/\/doi.org\/10.1001\/archopht.118.5.615.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"3760_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539\u201374. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001.","journal-title":"Ocul Surf"},{"issue":"1","key":"3760_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12886-023-02959-5","volume":"23","author":"Y Ren","year":"2023","unstructured":"Ren Y, Tian J, Shi W, et al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23(1):229. https:\/\/doi.org\/10.1186\/s12886-023-02959-5.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"3760_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/s1542-0124(12)70083-6","volume":"5","author":"Methodologies to diagnose and monitor dry eye disease","year":"2007","unstructured":"Methodologies to diagnose and monitor dry eye disease. report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):108\u201352. https:\/\/doi.org\/10.1016\/s1542-0124(12)70083-6.","journal-title":"Ocul Surf"},{"issue":"7","key":"3760_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640\u201350. https:\/\/doi.org\/10.1097\/00003226-200310000-00008.","journal-title":"Cornea"},{"issue":"4","key":"3760_CR33","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","volume":"52","author":"A Tomlinson","year":"2011","unstructured":"Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006\u201349. https:\/\/doi.org\/10.1167\/iovs.10-6997f.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 2","key":"3760_CR34","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1097\/ICL.0000000000000435","volume":"44","author":"H Pult","year":"2018","unstructured":"Pult H, Bandlitz S. Lid-Parallel Conjunctival Folds and Their Ability to Predict Dry Eye. Eye Contact Lens. 2018;44(Suppl 2):S113\u20139. https:\/\/doi.org\/10.1097\/ICL.0000000000000435.","journal-title":"Eye Contact Lens"},{"issue":"1","key":"3760_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/jop.2022.0107","volume":"39","author":"A Kumar","year":"2023","unstructured":"Kumar A, Chaurasiya D, Sultan S, et al. Therapeutic Profile of Human Umbilical Cord Blood Serum and Autologous Serum Therapies in Treatment of Ocular Surface Disorders: A Pilot Study. J Ocul Pharmacol Ther. 2023;39(1):36\u201347. https:\/\/doi.org\/10.1089\/jop.2022.0107.","journal-title":"J Ocul Pharmacol Ther Jan-Feb"},{"issue":"2","key":"3760_CR36","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1167\/iovs.16-20647","volume":"58","author":"A Javed","year":"2017","unstructured":"Javed A, Aslam T, Jones SA, Ashworth J. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. Invest Ophthalmol Vis Sci. 2017;58(2):954\u20138. https:\/\/doi.org\/10.1167\/iovs.16-20647.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3760_CR37","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bjophthalmol-2020-318547","volume":"106","author":"S Komai","year":"2022","unstructured":"Komai S, Inatomi T, Nakamura T, et al. Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases. Br J Ophthalmol. 2022;106(10):1355\u201362. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318547.","journal-title":"Br J Ophthalmol"},{"key":"3760_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jtos.2020.12.007","volume":"20","author":"B Ma","year":"2021","unstructured":"Ma B, Zhou Y, Liu R, et al. Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf. 2021;20:70\u201385. https:\/\/doi.org\/10.1016\/j.jtos.2020.12.007.","journal-title":"Ocul Surf"},{"issue":"2","key":"3760_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s1542-0124(12)70085-x","volume":"5","author":"Management and therapy of dry eye disease","year":"2007","unstructured":"Management and therapy of dry eye disease. report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):163\u201378. https:\/\/doi.org\/10.1016\/s1542-0124(12)70085-x.","journal-title":"Ocul Surf"},{"key":"3760_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101339","volume":"45","author":"DJ Dijkstra","year":"2019","unstructured":"Dijkstra DJ, Joeloemsingh JV, Bajema IM, Trouw LA. Complement activation and regulation in rheumatic disease. Semin Immunol. 2019;45: 101339. https:\/\/doi.org\/10.1016\/j.smim.2019.101339.","journal-title":"Semin Immunol"},{"issue":"9894","key":"3760_CR41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt F, O\u2019Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382(9894):797\u2013808. https:\/\/doi.org\/10.1016\/S0140-6736(13)61499-3.","journal-title":"Lancet"},{"key":"3760_CR42","doi-asserted-by":"publisher","unstructured":"Roda M, Corazza I, Bacchi Reggiani ML, et al. Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis. Int J Mol Sci. 2020;21(9). https:\/\/doi.org\/10.3390\/ijms21093111.","DOI":"10.3390\/ijms21093111"},{"issue":"1","key":"3760_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3899\/jrheum.190768","volume":"48","author":"MA Turk","year":"2021","unstructured":"Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular Manifestations in Rheumatoid Arthritis, Connective Tissue Disease, and Vasculitis: A Systematic Review and Metaanalysis. J Rheumatol. 2021;48(1):25\u201334. https:\/\/doi.org\/10.3899\/jrheum.190768.","journal-title":"J Rheumatol"},{"issue":"1","key":"3760_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12929-022-00821-2","volume":"29","author":"HH Wang","year":"2022","unstructured":"Wang HH, Chen WY, Huang YH, et al. Interleukin-20 is involved in dry eye disease and is a potential therapeutic target. J Biomed Sci. 2022;29(1):36. https:\/\/doi.org\/10.1186\/s12929-022-00821-2.","journal-title":"J Biomed Sci"},{"key":"3760_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102374","volume":"110","author":"M Aringer","year":"2020","unstructured":"Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun. 2020;110: 102374. https:\/\/doi.org\/10.1016\/j.jaut.2019.102374.","journal-title":"J Autoimmun"},{"issue":"2","key":"3760_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jtos.2019.12.005","volume":"18","author":"B Hu","year":"2020","unstructured":"Hu B, Qiu Y, Hong J. Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD). Ocul Surf. 2020;18(2):298\u2013304. https:\/\/doi.org\/10.1016\/j.jtos.2019.12.005.","journal-title":"Ocul Surf"},{"key":"3760_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaut.2016.11.003","volume":"77","author":"Y Chen","year":"2017","unstructured":"Chen Y, Chauhan SK, Tan X, Dana R. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. J Autoimmun. 2017;77:96\u2013103. https:\/\/doi.org\/10.1016\/j.jaut.2016.11.003.","journal-title":"J Autoimmun"},{"key":"3760_CR48","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3389\/fimmu.2020.01557","volume":"11","author":"I Markovic","year":"2020","unstructured":"Markovic I, Savvides SN. Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer. Front Immunol. 2020;11:1557. https:\/\/doi.org\/10.3389\/fimmu.2020.01557.","journal-title":"Front Immunol"},{"issue":"12","key":"3760_CR49","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"JT Barata","year":"2019","unstructured":"Barata JT, Durum SK, Seddon B. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 2019;20(12):1584\u201393. https:\/\/doi.org\/10.1038\/s41590-019-0479-x.","journal-title":"Nat Immunol"},{"issue":"3","key":"3760_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","volume":"24","author":"W Lundstrom","year":"2012","unstructured":"Lundstrom W, Fewkes NM, Mackall CL. IL-7 in human health and disease. Semin Immunol. 2012;24(3):218\u201324. https:\/\/doi.org\/10.1016\/j.smim.2012.02.005.","journal-title":"Semin Immunol"},{"issue":"12","key":"3760_CR51","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s10067-013-2360-x","volume":"32","author":"XS Wang","year":"2013","unstructured":"Wang XS, Li BZ, Hu LF, et al. Perspectives of the relationship between IL-7 and autoimmune diseases. Clin Rheumatol. 2013;32(12):1703\u20139. https:\/\/doi.org\/10.1007\/s10067-013-2360-x.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"3760_CR52","doi-asserted-by":"publisher","first-page":"103120","DOI":"10.1016\/j.autrev.2022.103120","volume":"21","author":"A Meyer","year":"2022","unstructured":"Meyer A, Parmar PJ, Shahrara S. Significance of IL-7 and IL-7R in RA and autoimmunity. Autoimmun Rev. 2022;21(7):103120. https:\/\/doi.org\/10.1016\/j.autrev.2022.103120.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3760_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/art.41558","volume":"73","author":"E Riviere","year":"2021","unstructured":"Riviere E, Pascaud J, Virone A, et al. Interleukin-7\/Interferon Axis Drives T Cell and Salivary Gland Epithelial Cell Interactions in Sjogren\u2019s Syndrome. Arthritis Rheumatol. 2021;73(4):631\u201340. https:\/\/doi.org\/10.1002\/art.41558.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3760_CR54","first-page":"115","volume":"36","author":"AN Burska","year":"2018","unstructured":"Burska AN, Neilan J, Chisman RE, et al. Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria. Clin Exp Rheumatol. 2018;36(1):115\u201320.","journal-title":"Clin Exp Rheumatol Jan-Feb"},{"issue":"11","key":"3760_CR55","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","volume":"79","author":"E Riviere","year":"2020","unstructured":"Riviere E, Pascaud J, Tchitchek N, et al. Salivary gland epithelial cells from patients with Sjogren\u2019s syndrome induce B-lymphocyte survival and activation. Ann Rheum Dis. 2020;79(11):1468\u201377. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216588.","journal-title":"Ann Rheum Dis"},{"key":"3760_CR56","doi-asserted-by":"publisher","first-page":"108758","DOI":"10.1016\/j.intimp.2022.108758","volume":"108","author":"Y Liang","year":"2022","unstructured":"Liang Y, Zhang Z, Li J, Luo W, Jiang T, Yang Z. Association between IL-7 and primary Sjogren\u2019s syndrome: A single-center study and a systematic scoping review. Int Immunopharmacol. 2022;108:108758. https:\/\/doi.org\/10.1016\/j.intimp.2022.108758.","journal-title":"Int Immunopharmacol"},{"key":"3760_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2018;63:40\u20137. https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.007.","journal-title":"Cancer Treat Rev"},{"key":"3760_CR58","doi-asserted-by":"publisher","unstructured":"Fallahi P, Ferrari SM, Ragusa F, et al. Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab. 2020;105(4). https:\/\/doi.org\/10.1210\/clinem\/dgz289.","DOI":"10.1210\/clinem\/dgz289"},{"key":"3760_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.654473","volume":"12","author":"P Fallahi","year":"2021","unstructured":"Fallahi P, Ferrari SM, Elia G, et al. Cytokines as Targets of Novel Therapies for Graves\u2019 Ophthalmopathy. Front Endocrinol (Lausanne). 2021;12: 654473. https:\/\/doi.org\/10.3389\/fendo.2021.654473.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3760_CR60","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fphar.2018.00641","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Chen W, Shen J. CXCR7 Targeting and Its Major Disease Relevance. Front Pharmacol. 2018;9:641. https:\/\/doi.org\/10.3389\/fphar.2018.00641.","journal-title":"Front Pharmacol"},{"key":"3760_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108209","volume":"201","author":"Y Wei","year":"2020","unstructured":"Wei Y, Asbell PA. sPLA2-IIa participates in ocular surface inflammation in humans with dry eye disease. Exp Eye Res. 2020;201: 108209. https:\/\/doi.org\/10.1016\/j.exer.2020.108209.","journal-title":"Exp Eye Res"},{"issue":"10","key":"3760_CR62","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.4049\/jimmunol.1400016","volume":"193","author":"TG Coursey","year":"2014","unstructured":"Coursey TG, Bohat R, Barbosa FL, Pflugfelder SC, de Paiva CS. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D\/RAE-1 and release of IFN-gamma in experimental dry eye. J Immunol. 2014;193(10):5264\u201372. https:\/\/doi.org\/10.4049\/jimmunol.1400016.","journal-title":"J Immunol"},{"issue":"10","key":"3760_CR63","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/1744666X.2021.1964957","volume":"17","author":"S Iwata","year":"2021","unstructured":"Iwata S, Tanaka Y. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus. Expert Rev Clin Immunol. 2021;17(10):1121\u201330. https:\/\/doi.org\/10.1080\/1744666X.2021.1964957.","journal-title":"Expert Rev Clin Immunol"},{"key":"3760_CR64","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Xia Y. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies. Front Immunol. 2019;10:1667. https:\/\/doi.org\/10.3389\/fimmu.2019.01667.","journal-title":"Front Immunol"},{"issue":"5","key":"3760_CR65","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3899\/jrheum.140677","volume":"42","author":"H Enocsson","year":"2015","unstructured":"Enocsson H, Sjowall C, Wirestam L, et al. Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity. J Rheumatol. 2015;42(5):817\u201325. https:\/\/doi.org\/10.3899\/jrheum.140677.","journal-title":"J Rheumatol"},{"key":"3760_CR66","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fimmu.2019.01104","volume":"10","author":"OP Rekvig","year":"2019","unstructured":"Rekvig OP. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. Front Immunol. 2019;10:1104. https:\/\/doi.org\/10.3389\/fimmu.2019.01104.","journal-title":"Front Immunol"},{"issue":"9","key":"3760_CR67","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1161\/ATVBAHA.121.315928","volume":"41","author":"AM Patino-Trives","year":"2021","unstructured":"Patino-Trives AM, Perez-Sanchez C, Perez-Sanchez L, et al. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arterioscler Thromb Vasc Biol. 2021;41(9):2417\u201330. https:\/\/doi.org\/10.1161\/ATVBAHA.121.315928.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3760_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102355","volume":"107","author":"IA Andrianova","year":"2020","unstructured":"Andrianova IA, Ponomareva AA, Mordakhanova ER, et al. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation. J Autoimmun. 2020;107: 102355. https:\/\/doi.org\/10.1016\/j.jaut.2019.102355.","journal-title":"J Autoimmun"},{"issue":"7","key":"3760_CR69","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.autrev.2016.02.019","volume":"15","author":"A Floris","year":"2016","unstructured":"Floris A, Piga M, Cauli A, Mathieu A. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review. Autoimmun Rev. 2016;15(7):656\u201363. https:\/\/doi.org\/10.1016\/j.autrev.2016.02.019.","journal-title":"\u00a0Autoimmun Rev"},{"key":"3760_CR70","doi-asserted-by":"publisher","unstructured":"Zeng Y, Xiao Y, Zeng F, et al. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity. Clin Exp Med. 2022. https:\/\/doi.org\/10.1007\/s10238-022-00942-w.","DOI":"10.1007\/s10238-022-00942-w"},{"issue":"2","key":"3760_CR71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/iid3.401","volume":"9","author":"X Shang","year":"2021","unstructured":"Shang X, Ren L, Sun G, et al. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Immun Inflamm Dis. 2021;9(2):407\u201318. https:\/\/doi.org\/10.1002\/iid3.401.","journal-title":"Immun Inflamm Dis"},{"issue":"6","key":"3760_CR72","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41385-018-0039-y","volume":"11","author":"KA Knoop","year":"2018","unstructured":"Knoop KA, Newberry RD. Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018;11(6):1551\u20137. https:\/\/doi.org\/10.1038\/s41385-018-0039-y.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"3760_CR73","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/OPX.0b013e318181ae4f","volume":"85","author":"B Caffery","year":"2008","unstructured":"Caffery B, Joyce E, Boone A, et al. Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom Vis Sci. 2008;85(8):661\u20137. https:\/\/doi.org\/10.1097\/OPX.0b013e318181ae4f.","journal-title":"Optom Vis Sci"},{"key":"3760_CR74","first-page":"1720","volume":"16","author":"B Caffery","year":"2010","unstructured":"Caffery B, Heynen ML, Joyce E, Jones L, Ritter R 3rd, Senchyna M. MUC1 expression in Sjogren\u2019s syndrome, KCS, and control subjects. Mol Vis. 2010;16:1720\u20137.","journal-title":"Mol Vis"},{"key":"3760_CR75","first-page":"2547","volume":"14","author":"B Caffery","year":"2008","unstructured":"Caffery B, Joyce E, Heynen ML, et al. MUC16 expression in Sjogren\u2019s syndrome, KCS, and control subjects. Mol Vis. 2008;14:2547\u201355.","journal-title":"Mol Vis"},{"key":"3760_CR76","doi-asserted-by":"publisher","unstructured":"Liu Y, Wu M, Ren Y, et al. Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Autoimmune Rheumatic Diseases. Ocul Immunol Inflamm. 2024:1\u201313. https:\/\/doi.org\/10.1080\/09273948.2024.2315196.","DOI":"10.1080\/09273948.2024.2315196"},{"issue":"4","key":"3760_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12649","volume":"87","author":"LW Zhang","year":"2018","unstructured":"Zhang LW, Zhou PR, Wei P, Cong X, Wu LL, Hua H. Expression of interleukin-17 in primary Sjogren\u2019s syndrome and the correlation with disease severity: A systematic review and meta-analysis. Scand J Immunol. 2018;87(4): e12649. https:\/\/doi.org\/10.1111\/sji.12649.","journal-title":"Scand J Immunol"},{"issue":"2","key":"3760_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/bjo.2011.202812","volume":"96","author":"JK Chung","year":"2012","unstructured":"Chung JK, Kim MK, Wee WR. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren\u2019s syndrome. Br J Ophthalmol. 2012;96(2):240\u20135. https:\/\/doi.org\/10.1136\/bjo.2011.202812.","journal-title":"Br J Ophthalmol"},{"key":"3760_CR79","doi-asserted-by":"publisher","unstructured":"Akcay Usta S, Icoz M. Evaluation of Ocular Surface Parameters and Systemic Inflammatory Biomarkers in Hazelnut Harvesters. Ocul Immunol Inflamm. 2024:1\u20136. https:\/\/doi.org\/10.1080\/09273948.2024.2336598.","DOI":"10.1080\/09273948.2024.2336598"},{"issue":"12","key":"3760_CR80","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1167\/iovs.19-27469","volume":"60","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Shin S, Yoon SG, Cheon EJ, Chung SH. The Effect of Chloroquine on the Development of Dry Eye in Sjogren Syndrome Animal Model. Invest Ophthalmol Vis Sci. 2019;60(12):3708\u201316. https:\/\/doi.org\/10.1167\/iovs.19-27469.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3760_CR81","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/1753425912471692","volume":"19","author":"E Villani","year":"2013","unstructured":"Villani E, Galimberti D, Del Papa N, Nucci P, Ratiglia R. Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study. Innate Immun. 2013;19(4):420\u20137. https:\/\/doi.org\/10.1177\/1753425912471692.","journal-title":"Innate Immun"},{"issue":"2","key":"3760_CR82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09273940701299354","volume":"15","author":"M Cordero-Coma","year":"2007","unstructured":"Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm Mar-Apr. 2007;15(2):99\u2013104. https:\/\/doi.org\/10.1080\/09273940701299354.","journal-title":"Ocul Immunol Inflamm Mar-Apr"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:18:05Z","timestamp":1731446285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3760"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03760-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects participated in the program voluntarily and signed informed consent forms. This study received approval from the clinical Research Ethics Committee of The Second Xiangya Hospital of Central South University (Ethics No.: Ocular Surface Observation in patients with systemic immune Diseases, LYF2021028). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"492"}}